Array ( [a_id] => 357828 [c_id] => 35678 [r_id] => 894 [rr_id] => 894 [m_id] => 1 [s_id] => 25768 [id_id] => 0 [v_id] => 0 [loc_id] => 0 [ft_id] => 0 [a_classification] => news [a_layout] => 1 [a_headline] => Genocea Stops Pneumonia Vaccine Development After Study Fails [a_sheadline] => Genocea Stops Pneumonia Vaccine Development After Study Fails [a_slug] => genocea-stops-pneumonia-vaccine-development-after-study-fails-357828 [a_subheadline] => [a_summary] => Drug developer Genocea Biosciences Inc said it was suspending the development of a vaccine for pneumonia-causing bacteria after it failed to significantly reduce infection in a mid-stage study. [a_article] =>
(Reuters) - Drug developer Genocea Biosciences Inc said it was suspending the development of a vaccine for pneumonia-causing bacteria after it failed to significantly reduce infection in a mid-stage study.
The company's shares fell 34 percent to $4.75 in premarket trading.
Genocea said it was dropping the development of the vaccine, GEN-004, from its near-term plans to focus on its lead drug - a treatment for genital herpes.
GEN-004 was being developed to fight streptococcus pneumoniae, a type of bacteria that causes a number of infectious diseases including bronchitis, conjunctivitis and brain abscess.
The World Health Organization estimates that up to 1.6 million people, including 800,000 children, die annually from infections caused by the bacteria.
During the trial, which included 98 adults, the vaccine showed consistent reductions in bacterial infection when compared with a placebo, but was not able to achieve statistical significance, the company said.
Genocea has been working on vaccines that target T-cells, a type of white blood cells that protect the body from infectious diseases and cancer.
There are no approved vaccines that work by targeting T-cells.
(Reporting by Amrutha Penumudi in Bengaluru; Editing by Don Sebastian)
[a_keyword] => Genocea Stops Pneumonia Vaccine Development After Study Fails [a_wordcount] => 185 [a_note] => [a_published] => 1 [a_updated] => 0 [a_writtenTime] => 2015-10-19 12:33:26 [a_submittedTime] => 2015-10-19 12:33:26 [a_modifiedTime] => 2015-10-19 12:33:25 [a_publishedTime] => 2015-10-19 12:33:26 [a_editor] => 1 [a_closeComment] => 1 [a_level] => 3 [a_social] => Genocea Stops Pneumonia Vaccine Development After Study Fails [a_commission] => 0 [a_countDown] => [a_countDownText] => [link] => https://www.medicaldaily.com/genocea-stops-pneumonia-vaccine-development-after-study-fails-357828 [c_type] => 1 [c_name] => The Grapevine [c_slug] => the-grapevine [c_ancestry] => -35678- [c_ancestry_slug] => [c_parent_id] => 0 [x_id] => 0 [c_text] =>Breaking News and Trends
[c_iab] => [c_order] => 0 [c_allow] => 1 [c_time] => 0000-00-00 00:00:00 [c_country] => [tid] => 35678 [c_parent] => Array ( [0] => 35678 ) [c_path] => Array ( [0] => The Grapevine ) [c_status] => Array ( [0] => 1 ) [c_path_slug] => Array ( [0] => the-grapevine ) [w] => [h] => [categories] => Array ( [0] => Array ( [c_id] => 35678 [c_type] => 1 [c_name] => The Grapevine [c_slug] => the-grapevine [c_ancestry] => -35678- [c_ancestry_slug] => [c_parent_id] => 0 [x_id] => 0 [c_text] =>Breaking News and Trends
[c_iab] => [c_order] => 0 [c_allow] => 1 [c_time] => 0000-00-00 00:00:00 [c_country] => [tid] => 35678 [c_parent] => Array ( [0] => 35678 ) [c_path] => Array ( [0] => The Grapevine ) [c_status] => Array ( [0] => 1 ) [c_path_slug] => Array ( [0] => the-grapevine ) [w] => [h] => ) ) [real] => Array ( [ar_id] => 8122 [a_id] => 357828 [r_id] => 894 [ar_num] => 0 [ar_prefix] => [ar_suffix] => [ar_show] => 1 [ar_weight] => 0 [ar_replace] => [id_id] => 0 [r_img_show] => 0 [r_name] => Reuters [r_slug] => reporters/reuters [r_title] => [r_prefix] => [r_suffix] => [r_type] => [r_desc] => [r_email] => thisisnotreal@notreal1.com [r_facebook] => [r_twitter] => [r_linkedin] => [r_country] => [r_team] => 0 [r_nef] => [r_company] => [r_article_count] => 804 [r_aid] => 0 [r_parent_id] => 0 [r_allow] => 1 [r_active] => 0 [cen_r_id] => 0 [r_time] => 2014-09-08 09:04:19 [temp_id] => 0 ) [reporters] => Array ( [0] => Array ( [ar_id] => 8122 [a_id] => 357828 [r_id] => 894 [ar_num] => 0 [ar_prefix] => [ar_suffix] => [ar_show] => 1 [ar_weight] => 0 [ar_replace] => [id_id] => 0 [r_img_show] => 0 [r_name] => Reuters [r_slug] => reporters/reuters [r_title] => [r_prefix] => [r_suffix] => [r_type] => [r_desc] => [r_email] => thisisnotreal@notreal1.com [r_facebook] => [r_twitter] => [r_linkedin] => [r_country] => [r_team] => 0 [r_nef] => [r_company] => [r_article_count] => 804 [r_aid] => 0 [r_parent_id] => 0 [r_allow] => 1 [r_active] => 0 [cen_r_id] => 0 [r_time] => 2014-09-08 09:04:19 [temp_id] => 0 ) ) [reporterAll] => Array ( [0] => Array ( [r_id] => 894 [r_name] => Reuters [r_team] => 0 [r_slug] => reporters/reuters [ar_weight] => 0 ) ) [reviews] => Array ( ) [s_name] => Reuters2012 [s_slug] => reuters2012 [s_credit] => @ 2012 Thomson Reuters. All rights reserved. [web_id] => 0 [s_aid] => 0 [cen_s_id] => 0 [s_url] => [s_order] => 0 [s_photo] => [s_allow] => 1 [a_facebook] => 0 [a_twitter] => 0 [a_plus] => 0 [a_linkedin] => 0 [a_reddit] => 0 [a_views] => 0 [r_headline] => Genocea Stops Pneumonia Vaccine Development After Study Fails [a_error] => 0 [a_search] => Genocea Stops Pneumonia Vaccine Development After Study Fails [a_h1] => [a_standout] => 0 [a_standouted] => 0 [a_special] => [a_rshare] => 0 [a_applenews_id] => [a_applenews_revision] => [a_url_slug] => [a_noindex] => 0 [a_link] => [a_syndication] => 1 [a_meta_description] => [a_key_points] => [a_tier] => [a_value1] => [a_value2] => 0 [a_weight] => 0 [a_whitelist] => 1 [a_permanant_whitelist] => 0 [a_parent_id] => 0 [a_web_id] => 0 [a_rank] => 0 [a_ads] => 1 [a_google_ai] => 0 [a_disclaimer] => 1 [a_cloudsearch] => 0 [a_json] => [keywords] => Array ( [0] => Array ( [k_id] => 10269 [k_keyword] => Pneumonia [k_page_title] => [k_meta_description] => Pneumonia is an inflammatory condition of the lung—especially affecting the microscopic air sacs — associated with fever, chest symptoms, and a lack of air space on a chest X-ray. Pneumonia is typically caused by an infection but there are a n [k_slug] => pneumonia [k_type] => 0 [id_id] => [file_id] => 0 [c_id] => 0 [m_id] => 1 [k_text] => Pneumonia is an inflammatory condition of the lung—especially affecting the microscopic air sacs — associated with fever, chest symptoms, and a lack of air space on a chest X-ray. Pneumonia is typically caused by an infection but there are a number of other causes. Typical symptoms include cough, chest pain, fever, and difficulty breathing. [k_tree] => 10269 [k_parent_id] => 0 [k_ancestry] => -10269- [k_level] => 0 [k_article] => [k_allow] => 2 [k_time] => 2010-07-12 18:29:33 [k_photo] => [k_tid] => 26616 [k_tslug] => conditions/pneumonia [k_approved] => 0 ) [1] => Array ( [k_id] => 15167 [k_keyword] => Genocea Stops Pneumonia Vaccine Development After Study Fails [k_page_title] => [k_meta_description] => [k_slug] => genocea-stops-pneumonia-vaccine-development-after-study-fails [k_type] => 0 [id_id] => [file_id] => [c_id] => 0 [m_id] => 1 [k_text] => [k_tree] => 15167 [k_parent_id] => 0 [k_ancestry] => -15167- [k_level] => 0 [k_article] => [k_allow] => 1 [k_time] => 2015-10-19 12:33:26 [k_photo] => [k_tid] => 0 [k_tslug] => [k_approved] => 0 ) ) [shorten] => [locations] => Array ( ) [related] => Array ( ) [channels] => Array ( ) [graphic] => Array ( ) [feature] => Array ( ) [topics] => Array ( [0] => Array ( [k_id] => 10269 [k_keyword] => Pneumonia [k_page_title] => [k_meta_description] => Pneumonia is an inflammatory condition of the lung—especially affecting the microscopic air sacs — associated with fever, chest symptoms, and a lack of air space on a chest X-ray. Pneumonia is typically caused by an infection but there are a n [k_slug] => pneumonia [k_type] => 0 [id_id] => [file_id] => 0 [c_id] => 0 [m_id] => 1 [k_text] => Pneumonia is an inflammatory condition of the lung—especially affecting the microscopic air sacs — associated with fever, chest symptoms, and a lack of air space on a chest X-ray. Pneumonia is typically caused by an infection but there are a number of other causes. Typical symptoms include cough, chest pain, fever, and difficulty breathing. [k_tree] => 10269 [k_parent_id] => 0 [k_ancestry] => -10269- [k_level] => 0 [k_article] => [k_allow] => 2 [k_time] => 2010-07-12 18:29:33 [k_photo] => [k_tid] => 26616 [k_tslug] => conditions/pneumonia [k_approved] => 0 [k_count] => 52 ) ) [first_info] => Array ( [eh_id] => 16254 [eh_what] => article [a_id] => 357828 [eh_type] => imageBox [eh_align] => block [eh_width] => 736 [eh_height] => [eh_w] => 736 [eh_h] => 0 [eh_position] => -2 [eh_text] => [eh_parent] => 0 [eh_num] => 0 [eh_time] => 2015-10-19 12:33:26 [eh_x1] => 357826 [eh_d1] => 357826 [eh_d2] => [eh_d3] => A vial of experimental flu vaccine is seen during a clinical trial to test the effectiveness of the vaccine to combat avian influenza April 5, 2005 at University of Maryland School of Medicine in Baltimore, Maryland. [eh_d4] => [eh_d5] => A vial of experimental flu vaccine. [eh_d6] => [eh_d7] => [eh_d8] => [eh_d9] => [eh_d10] => [eh_d11] => ) [review_item] => Array ( ) [a_content_first] => [a_content] =>(Reuters) - Drug developer Genocea Biosciences Inc said it was suspending the development of a vaccine for pneumonia-causing bacteria after it failed to significantly reduce infection in a mid-stage study.
The company's shares fell 34 percent to $4.75 in premarket trading.
Genocea said it was dropping the development of the vaccine, GEN-004, from its near-term plans to focus on its lead drug - a treatment for genital herpes.
GEN-004 was being developed to fight streptococcus pneumoniae, a type of bacteria that causes a number of infectious diseases including bronchitis, conjunctivitis and brain abscess.
The World Health Organization estimates that up to 1.6 million people, including 800,000 children, die annually from infections caused by the bacteria.
During the trial, which included 98 adults, the vaccine showed consistent reductions in bacterial infection when compared with a placebo, but was not able to achieve statistical significance, the company said.
Genocea has been working on vaccines that target T-cells, a type of white blood cells that protect the body from infectious diseases and cancer.
There are no approved vaccines that work by targeting T-cells.
(Reporting by Amrutha Penumudi in Bengaluru; Editing by Don Sebastian)
[a_content_last] => [a_aside] => [a_content_first_type] => imageBox [a_content_last_type] => [a_content_embed] => [reps] => Array ( [0] => Reuters ) [repid] => Array ( [0] => 894 ) [image] => Array ( [id_id] => 357826 [id_name] => A vial of experimental flu vaccine. [id_caption] => A vial of experimental flu vaccine is seen during a clinical trial to test the effectiveness of the vaccine to combat avian influenza April 5, 2005 at University of Maryland School of Medicine in Baltimore, Maryland. [id_short_caption] => flu-vaccine [id_credit] => Getty Images [id_keyword] => [id_gallery] => [id_adult] => 0 [id_hide] => 0 [id_source] => [id_photographer] => [id_text] => [id_ext] => jpg [id_location] => [id_width] => 2500 [id_height] => 1667 [id_left] => 50 [id_top] => 40 [id_quality] => 85 [id_filesize] => 541567 [s_id] => [m_id] => 894 [x_id] => 0 [id_time] => 2015-10-19 12:20:57 [id_submittedTime] => 2015-10-19 12:20:57 [id_url] => [id_published] => 1 [img_name] => public://2015/10/19/vial-experimental-flu-vaccine.jpg [ori] => https://d.medicaldaily.com/en/full/357826/vial-experimental-flu-vaccine.jpg [src] => https://d.medicaldaily.com/en/full/357826/vial-experimental-flu-vaccine.jpg [tag] => src="https://d.medicaldaily.com/en/full/357826/vial-experimental-flu-vaccine.jpg" alt="A vial of experimental flu vaccine. " [picture] =>